The PNC Financial Services Group (PNC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Beyond analysts' top-and-bottom-line estimates for Wells Fargo (WFC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.

Casey's (CASY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Besides Wall Street's top-and-bottom-line estimates for H. B. Fuller (FUL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended November 2025.

Evaluate the expected performance of United Community Banks (UCB) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Small-cap stocks are finally having their moment. After years of mega-cap tech dominance, the Russell 2000 is surging in the first week of 2026, outpacing both the S&P 500 and Nasdaq-100.

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

VWO is a passive ETF, in my opinion an intelligent proxy of the emerging market (China included). Even today it has attractive valuations compared to developed markets, with a P/E of 16x thanks to an estimated EPS growth rate of about 16.5%. But valuations might not be enough, VWO could find itself trapped by post–Trump intervention macro dynamics in Venezuela and beyond.

Bonds offering 4% yields are losing their purchasing power when real inflation is somewhere between 6% to 12%, according to celebrated economist

STE is buoyed by strong Healthcare and AST growth, solid margins and balance sheet strength, even as macro pressures and competition loom.

LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bitdeer Technologies Group (“Bitdeer” or “the Company”) (NASDAQ: BTDR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 6, 2024 through November 10, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before February 2, 2026.

The AI trade has grown quite volatile of late, but for investors who aren't deterred by the AI bubble concerns of others, I think there's a great opportunity to pursue a class of stocks that stand to gain from AI but aren't yet priced with such AI-driven catalysts in mind.

PHILADELPHIA, Jan. 09, 2026 (GLOBE NEWSWIRE) -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Klarna Group plc (NYSE: KLAR) (“Klarna” or the “Company”) on behalf of investors who purchased or otherwise acquired Klarna securities during the period of September 7, 2025 through December 22, 2025 (the “Class Period”), including shares issued pursuant and/or traceable to Klarna's September 2025 initial public offering (“IPO”).

FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORM A TION Name of person dealing (Note 1) State Street Global Advisors & Affiliates Company dealt in Avadel Pharmaceuticals plc Class of relevant security to which the dealings being disclosed relate (Note 2) $0.01 ordinary shares Date of dealing 8th January 2026 2.

Medical services stocks like MEDP, EHAB and PGNY benefit from tech-driven care models even as staffing gaps pressure margins.

Block & Leviton is investigating Aquestive Therapeutics (Nasdaq: AQST) for possible securities fraud. Investors who lost money should contact the firm.

We love exciting spectacles. We should — but don't always — also appreciate behind the scenes grunt work that although seemingly dull, is indispensable to making the spectacle possible. That's so in the business world too. We see lots of exciting tech nowadays, especially with AI. But don't underestimate the boring backstage stuff that makes it possible. nVent Electric, spun off from Pentair in 2018, is known for producing a lot of these yawn-worthy necessities: connectors for wires and cables, and enclosures to safeguard them.

Procter & Gamble (PG) offers a compelling buy opportunity as a high-quality, low-beta compounder at a multi-year valuation low. PG has delivered consistent top- and bottom-line growth, with TTM revenue rising from $73B to $84B and TTM profits growing from $13.9B to $16.7B over the last five years. Management has reduced share count by 7% since 2021 through disciplined buybacks, supporting EPS growth and long-term shareholder value.

WDC's HDD business is powering revenue growth as hyperscale demand lifts exabyte shipments, high-capacity drive adoption and outlook.